Immunogenicity and safety of measles-mumps-rubella vaccine delivered by disposable-syringe jet injector in India: A randomized, parallel group, non-inferiority trial
Vaccine Feb 28, 2018
Bavdekar A, et al. - Researchers examined the immunogenicity and safety of measles-mumps-rubella (MMR) vaccine delivered by a disposable-syringe jet injector (DSJI) in toddlers in India, relative to the conventional administration. They found that MMR vaccination via DSJI was as immunogenic as vaccination by needle-syringe (N-S). Except for injection site reactions which were more with DSJI and were well-tolerated, DSJI method demonstrated safety profile similar to N-S.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries